Latanoprost Sifi

Latanoprost, the active ingredient in Latanoprost Sifi, is a prostaglandin analog presented as eye drops for ocular use. It lowers intraocular pressure in adults with primary open-angle glaucoma or ocular hypertension, helping to preserve visual function. It is indicated for patients who require long‑term management of elevated eye pressure to prevent optic nerve damage.

GNH USA supplies Latanoprost Sifi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global logistics for regulated eye‑care products.

Latanoprost is a prostaglandin analog used to lower intraocular pressure in glaucoma and ocular hypertension.

- Primary open-angle glaucoma: reduces intraocular pressure to slow disease progression. - Ocular hypertension: lowers eye pressure to prevent conversion to glaucoma. - Secondary open-angle glaucoma: helps control pressure when other therapies are insufficient. - Pseudoexfoliative glaucoma: decreases pressure to protect the optic nerve.

Latanoprost may cause ocular and systemic reactions; reported events are categorized by frequency.

Common Side Effects: - Eye redness: mild conjunctival hyperemia after drop instillation. - Increased eyelash length: growth of longer, thicker lashes. - Iris pigmentation change: gradual darkening of the iris color. - Eye irritation: transient burning or stinging sensation.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Uveitis: inflammation of the uveal tract that may impair vision. - Macular edema: swelling of the central retina that can reduce visual acuity.

When prescribing Latanoprost, clinicians should consider several safety precautions to minimize risks.

- Pregnancy: safety not established; use only if benefits outweigh risks. - Breastfeeding: insufficient data; consider alternatives. - Intraocular pressure monitoring: check pressure after starting therapy. - Ocular infection: do not use if active eye infection is present. - Contact lenses: remove lenses before instilling drops and wait before reinserting. - Store at room temperature: keep bottle in original container, protect from light and moisture.

Latanoprost can interact with other ophthalmic or systemic agents; awareness of these interactions helps avoid reduced efficacy or increased adverse effects.

Major Interactions (Avoid): - Nonsteroidal anti‑inflammatory eye drops: may diminish Latanoprost's IOP‑lowering effect. - Systemic prostaglandin analogs: can increase risk of ocular side effects. - Anticholinergic eye drops: may reduce therapeutic efficacy.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive intraocular pressure reduction may require monitoring. - Carbonic anhydrase inhibitor eye drops: may increase ocular irritation. - Corticosteroid eye drops: potential heightened risk of cataract formation.